Travelling with cystic fibrosis: Recommendations for patients and care team members

Journal of Cystic Fibrosis

Volumn 9, Issue 6, 2010, Pages 385-399

  Hirche, T O ^a   Bradley, J ^b   d'Alquen, D ^c   De Boeck, K ^d   Dembski, B ^e   Elborn, J S ^f   Gleiber, W ^g   Lais, C ^g   Malfroot, A ^h   Wagner, T O F ^g  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e CF Europe   (Germany)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^g UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^h UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Cystic fibrosis; Holidays; Travelling; Vacation

Indexed keywords

AZITHROMYCIN; BCG VACCINE; CHICKENPOX VACCINE; CHLORAMPHENICOL; CHOLERA VACCINE; CIPROFLOXACIN; DEOXYRIBONUCLEASE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; DOXYCYCLINE; FLUCLOXACILLIN; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; ROTAVIRUS VACCINE; SALBUTAMOL; SODIUM CHLORIDE; TICK BORNE ENCEPHALITIS VACCINE; TOBRAMYCIN; TYPHOID VACCINE; UNINDEXED DRUG; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ALTITUDE; ARTERIAL OXYGEN SATURATION; AVIATION; BACTERIAL TRANSMISSION; BLEEDING; BLOOD GAS ANALYSIS; BRONCHOSPASM; CYSTIC FIBROSIS; DEHYDRATION; EUROPE; EXERCISE; FLUID INTAKE; FORCED EXPIRATORY VOLUME; FRACTURE; GRAFT RECIPIENT; HEALTH INSURANCE; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEMOPTYSIS; HUMAN; HYPOGLYCEMIA; HYPOXEMIA; HYPOXIA; ICELAND; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LUNG CLEARANCE; LUNG INFECTION; MEDICAL INFORMATION; NORWAY; OXYGEN TENSION; OXYGENATION; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PHOTOSENSITIVITY; PHYSICAL ACTIVITY; PNEUMOTHORAX; PSEUDOMONAS INFECTION; REVIEW; SODIUM DEPLETION; SPORT; SWITZERLAND; TRAVEL; VACCINATION;

ANOXIA; CAREGIVERS; CYSTIC FIBROSIS; GUIDELINES AS TOPIC; HEALTH EDUCATION; HUMANS; INFECTION; RISK FACTORS; TRAVEL;

EID: 78650223550     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.08.013     Document Type: Review

References (76)

1. Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005, 4(1):7-26.
2. Doring G., Conway S.P., Heijerman H.G., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16(4):749-767.
3. Sinaasappel M., Stern M., Littlewood J., et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002, 1(2):51-75.
4. Doring G., Hoiby N. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004, 3(2):67-91.
5. Malfroot A., Adam G., Ciofu O., et al. Immunisation in the current management of cystic fibrosis patients. J Cyst Fibros 2005, 4(2):77-87.
6. Doring G., Elborn J.S., Johannesson M., et al. Clinical trials in cystic fibrosis. J Cyst Fibros 2007, 6(2):85-99.
7. Castellani C., Cuppens H., Macek M., et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008, 7(3):179-196.
8. Mayell S.J., Munck A., Craig J.V., et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros 2009, 8(1):71-78.
9. Gong H. Air travel and oxygen therapy in cardiopulmonary patients. Chest 1992, 101(4):1104-1113.
10. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987, (1):225-244.
11. British Thoracic Society Standards of Care Committee Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 2002, 57(4):289-304.
12. Cogo A., Fischer R., Schoene R. Respiratory diseases and high altitude. High Alt Med Biol 2004, 5(4):435-444.
13. Waisman Y., Klein B.L., Rachmel A., Garty B.Z., Nitzan M. In-flight esophageal variceal bleeding en route for liver transplantation: a case report and review of the literature. Pediatr Emerg Care 1991, 7(3):157-159.
14. Dillard T.A., Berg B.W., Rajagopal K.R., Dooley J.W., Mehm W.J. Hypoxemia during air travel in patients with chronic obstructive pulmonary disease. Ann Intern Med 1989, 111(5):362-367.
15. Dillard T.A., Beninati W.A., Berg B.W. Air travel in patients with chronic obstructive pulmonary disease. Arch Intern Med 1991, 151(9):1793-1795.
16. Dillard T.A., Rosenberg A.P., Berg B.W. Hypoxemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease. Chest 1993, 103(2):422-425.
17. Dillard T.A., Moores L.K., Bilello K.L., Phillips Y.Y. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. Chest 1995, 107(2):352-357.
18. Gong H. Advising patients with pulmonary diseases on air travel. Ann Intern Med 1989, 111(5):349-351.
19. Gong H. Air travel and patients with pulmonary and allergic conditions. J Allergy Clin Immunol 1991, 87(4):879-885.
20. Gong H. Air travel and oxygen therapy in cardiopulmonary patients. Chest 1992, 101(4):1104-1113.
21. Gong H., Mark J.A., Cowan M.N. Preflight medical screenings of patients. Analysis of health and flight characteristics. Chest 1993, 104(3):788-794.
22. Oades P.J., Buchdahl R.M., Bush A. Prediction of hypoxaemia at high altitude in children with cystic fibrosis. BMJ 1994, 308(6920):15-18.
23. Buchdahl R.M., Babiker A., Bush A., Cramer D. Predicting hypoxaemia during flights in children with cystic fibrosis. Thorax 2001, 56(11):877-879.
24. Fischer R., Lang S.M., Bruckner K., et al. Lung function in adults with cystic fibrosis at altitude: impact on air travel. Eur Respir J 2005, 25(4):718-724.
25. Aerospace MedicalAssociation Medical Guidelines Task Force. Aviat Space Environ Med 2003, 7:A1-A19. 2nd ed.
26. Kelly P.T., Swanney M.P., Seccombe L.M., et al. Air travel hypoxemia vs. the hypoxia inhalation test in passengers with COPD. Chest 2008, 133(4):920-926.
27. Naughton M.T., Rochford P.D., Pretto J.J., et al. Is normobaric simulation of hypobaric hypoxia accurate in chronic airflow limitation?. Am J Respir Crit Care Med 1995, 152(6 Pt 1):1956-1960.
28. Thews O., Fleck B., Kamin W.E., Rose D.M. Respiratory function and blood gas variables in cystic fibrosis patients during reduced environmental pressure. Eur J Appl Physiol 2004, 92(4-5):493-497.
29. Christensen C.C., Ryg M., Refvem O.K., Skjonsberg O.H. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2, 438m (8, 000 ft) altitude. Eur Respir J 2000, 15(4):635-639.
30. Naughton M.T., Rochford P.D., Pretto J.J., et al. Is normobaric simulation of hypobaric hypoxia accurate in chronic airflow limitation?. Am J Respir Crit Care Med 1995, 152(6 Pt 1):1956-1960.
31. Rose D.M., Fleck B., Thews O., Kamin W.E. Blood gas-analyses in patients with cystic fibrosis to estimate hypoxemia during exposure to high altitudes in a hypobaric-chamber. Eur J Med Res 2000, 5(1):9-12.
32. Seccombe L.M., Kelly P.T., Wong C.K., et al. Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease. Thorax 2004, 59(11):966-970.
33. Rose D.M., Fleck B., Thews O., Kamin W.E. Blood gas-analyses in patients with cystic fibrosis to estimate hypoxemia during exposure to high altitudes in a hypobaric-chamber. Eur J Med Res 2000, 5(1):9-12.
34. Peckham D., Watson A., Pollard K., Etherington C., Conway S.P. Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis. J Cyst Fibros 2002, 1(4):281-286.
35. van der Meer H., Kimpen J.L. Insufficient vaccination status of children with a chronic disease. Ned Tijdschr Geneeskd 1996, 140(27):1402-1406.
36. De Schutter I., De Wachter E., Hauser B., Anckaert E., Malfroot A. Seroconversion after Hepatitis B and Hepatitis A vaccination in CF patients. J Cyst Fibros 2007, 6(1 (Supplement)):S96.
37. Van Damme P., Leroux-Roels G., Law B., et al. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol 2001, 65(1):6-13.
38. WHO vaccine preventable disease monitoring system 2009, World Health Organization, WHO web site.
39. Country list: yellow fever vaccination requirements and recommendations; and malaria situation 2008, World Health Organization, WHO web site.
40. Malfroot A., De Wachter E., Pierard D. Vaceine failure in CF. J Cyst Fibros 2005, 4 (suppl).
41. O'Carroll M.R., Kidd T.J., Coulter C., et al. Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis. Thorax 2003, 58(12):1087-1091.
42. Holland D.J., Wesley A., Drinkovic D., Currie B.J. Cystic fibrosis and Burkholderia pseudomallei infection: an emerging problem?. Clin Infect Dis 2002, 35(12):e138-e140.
43. Visca P., Cazzola G., Petrucca A., Braggion C. Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis 2001, 32(1):E15-E16.
44. Verma A., Dodd M.E., Haworth C.S., Webb A.K. Holidays and cystic fibrosis. J R Soc Med 2000, 93(Suppl 38):20-26.
45. Mussion H., Nicholas A., Webb K., Nowell S. Staff and patients at Manchester Adult CF unit. Planning a holiday 2004, Bradbury Cystic Fibrosis Unit, Manchester.
46. Orenstein D.M. Cystic fibrosis: a guide for patient and family 2003, Lippincott Williams & Wilkins, Philadelphia. 3rd edn.
47. Kessler W.R., Andersen D.H. Heat prostration in fibrocystic disease of the pancreas and other conditions. Pediatrics 1951, 8(5):648-656.
48. Danks D.M., Webb D.W., Allen J. Heat illness in infants and young children: a study of 47 cases. Br Med J 1962, 1(ii):287-293.
49. Williams A.J., McKiernan J., Harris F. Letter: Heat prostration in children with cystic fibrosis. Br Med J 1976, 2(6030):297.
50. Orenstein D.M., Henke K.G., Costill D.L., et al. Exercise and heat stress in cystic fibrosis patients. Pediatr Res 1983, 17(4):267-269.
51. Bar-Or O., Blimkie C.J., Hay J.A., et al. Voluntary dehydration and heat intolerance in cystic fibrosis. Lancet 1992, 339(8795):696-699.
52. Kriemler S., Wilk B., Schurer W., Wilson W.M., Bar-Or O. Preventing dehydration in children with cystic fibrosis who exercise in the heat. Med Sci Sports Exerc 1999, 31(6):774-779.
53. Gruber W., Hebestreit A., Hebestreit H. Arbeitskreis Sport des Mukoviszidose e.V. Leitfaden Sport bei Mukoviszidose. Bonn 2004, 1st edn.
54. Orenstein D.M., Henke K.G., Green C.G. Heat acclimation in cystic fibrosis. J Appl Physiol 1984, 57(2):408-412.
55. Webb A.K., Dodd M.E. Exercise and sport in cystic fibrosis: benefits and risks. Br J Sports Med 1999, 33(2):77-78.
56. Speechly-Dick M.E., Rimmer S.J., Hodson M.E. Exacerbations of cystic fibrosis after holidays at high altitude-a cautionary tale. Respir Med 1992, 86(1):55-56.
57. Moorcroft A.J., Dodd M.E., Webb A.K. Exercise limitations and training for patients with cystic fibrosis. Disabil Rehabil 1998, 20(6-7):247-253.
58. Orenstein D.M. Cystic fibrosis. Sports and Exercise for Children with Chronic Health Conditions 1995, 167-186. Human Kinetics, Champaign, IL. B. Goldberg (Ed.).
59. Hebestreit H., Kriemler S., Hebestreit A. Körperliche Aktivität und Training bei Mukoviszidose. Dtsch Z Sportmed 2000, 51:85-93.
60. Ruf K., Hebestreit H. Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis. J Cyst Fibros 2009, 8(2):83-90.
61. Haworth C.S., Selby P.L., Webb A.K., et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999, 54(11):961-967.
62. Haworth C.S., Selby P.L., Webb A.K., Adams J.E. Osteoporosis in adults with cystic fibrosis. J R Soc Med 1998, 91(Suppl 34):14-18.
63. Murphy D., O'Mahony M., Logan P., Costello R., McElvaney N. Bilateral pneumothoraces following a bungee jump in a patient with cystic fibrosis. Respiration 2006, 73(1):113.
64. Barben J., Hafen G., Schmid J. Pseudomonas aeruginosa in public swimming pools and bathroom water of patients with cystic fibrosis. J Cyst Fibros 2005, 4(4):227-231.
65. Moore J.E., Heaney N., Millar B.C., Crowe M., Elborn J.S. Incidence of Pseudomonas aeruginosa in recreational and hydrotherapy pools. Commun Dis Public Health 2002, 5(1):23-26.
66. Moore J.E., Goldsmith C.E., Millar B.C., et al. Cystic fibrosis and the isolation of Pseudomonas aeruginosa from horses. Vet Rec 2008, 163(13):399-400.
67. Blau H., Mussaffi-Georgy H., Fink G., et al. Effects of an intensive 4-week summer camp on cystic fibrosis: pulmonary function, exercise tolerance, and nutrition. Chest 2002, 121(4):1117-1122.
68. Pegues D.A., Carson L.A., Tablan O.C., et al. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr 1994, 124(5 Pt 1):694-702.
69. Fluge G., Ojeniyi B., Hoiby N., et al. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin Microbiol Infect 2001, 7(5):238-243.
70. Brimicombe R.W., Dijkshoorn L., van der Reijden T.J., et al. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 2008, 7(1):30-36.
71. Cystic Fibrosis Worldwide Hygiene guidelines for people with cystic fibrosis when attending CF related events. CF Worldwide / CF Europe 2008, www.cfww.org.
72. Cystic Fibrosis Worldwide Conference/Meeting: anti cross-infection requirements for people with cystic fibrosis. CF Worldwide / CF Europe 2008, www.cfww.org.
73. Lim E., Koh W.H., Loh S.F., Lam M.S., Howe H.S. Non-thyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001, 10(2):87-92.
74. Dhar J.M., al Khader A.A., al Sulaiman M., al Hasani M.K. Non-typhoid Salmonella in renal transplant recipients: a report of twenty cases and review of the literature. Q J Med 1991, 78(287):235-250.
75. Gumbo T., Hobbs R.E., Carlyn C., Hall G., Isada C.M. Microsporidia infection in transplant patients. Transplantation 1999, 67(3):482-484.
76. Avery R.K., Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant 2008, 8(1):9-14.